51
Participants
Start Date
June 4, 2018
Primary Completion Date
November 10, 2023
Study Completion Date
November 10, 2023
Once daily immunosuppression regimen
Intervention focuses on the type of regimen, in this case the intervention arm will receive a once daily regimen for immunosuppression compared to the twice daily regimen.
Twice daily immunosuppression regimen
This is the arm which we are designating the standard, which will be the comparison to the active drug arm.
Washington University, St Louis
Collaborators (1)
Veloxis Pharmaceuticals
INDUSTRY
Washington University School of Medicine
OTHER